CN105999073A - Medicine composition for treating chronic sinusitis and preparation method thereof - Google Patents

Medicine composition for treating chronic sinusitis and preparation method thereof Download PDF

Info

Publication number
CN105999073A
CN105999073A CN201610487768.5A CN201610487768A CN105999073A CN 105999073 A CN105999073 A CN 105999073A CN 201610487768 A CN201610487768 A CN 201610487768A CN 105999073 A CN105999073 A CN 105999073A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
rhizoma
chronic sinusitis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610487768.5A
Other languages
Chinese (zh)
Inventor
陈令浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Chenda Biotechnology Co Ltd
Original Assignee
Qingdao Chenda Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Chenda Biotechnology Co Ltd filed Critical Qingdao Chenda Biotechnology Co Ltd
Priority to CN201610487768.5A priority Critical patent/CN105999073A/en
Publication of CN105999073A publication Critical patent/CN105999073A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine composition for treating chronic sinusitis and a preparation method thereof. The medicine composition is prepared from the following traditional Chinese medicinal materials: radix pseudostellariae, poria cocos, coix seeds, fructus forsythiae, herba patriniae, rhizoma wenyujin concisum, cassia twigs, asarum, radices ligustici sinensis, gleditsia sinensis, platycodon grandiflorum, cynanchum glaucescens, sinapis semina and radix paeoniae rubra. The medicine composition has remarkable effects of clearing heat, drying dampness, tonifying qi, strengthening the spleen, promoting blood circulation to remove stasis, restoring consciousness, resolving depression, resolving turbidity and draining pus, and can be used for effectively treating chronic sinusitis caused by various reasons and improving the living quality of patients. Clinical experiment observation shows that the medicine composition has a total effective rate for treating chronic sinusitis of 98 percent, and is worthy of popularization and application.

Description

A kind of pharmaceutical composition treating chronic sinusitis and preparation method thereof
Technical field
Present invention pharmaceutical composition treating chronic sinusitis and preparation method thereof belongs to technical field of Chinese medicines, is specifically related to A kind of Chinese medicine preparation treating chronic sinusitis and production method thereof.
Background technology
Sinusitis is the nonspecific inflammation of sinus mucosa, the common frdquently encountered disease of Shi Zhong nose section.In various sinusitis, Maxillary sinusitis is the most common, secondly for sieve hole, sinus frontalis and the inflammation of sphenoid sinus, can be with single-shot, and can also be multiple, modal pathogenic former Because secondary nasal sinuses suppurative inflammation after nasal cavity infection.
Sinusitis can be divided into acute and chronic two big classes, and acute purulent nasosinusitis is secondary to acute rhinitis more, with nasal obstruction, Many pus tears, have a headache for principal character；Chronic purulent sinusitis is often secondary to acute purulent nasosinusitis, is main with many pus tears Performance, the nasal obstruction that can differ with weight, headache and olfactory disorder.It mostly is chronic sinusitis clinically.The traditional Chinese medical science thinks that nose is clear Key, for the door of lung, it is unimpeded that it is breathed, and the sensitive complete of olfactory sensation relies clear sun to supplement nutrition.Sinusitis is not how solid by the deficiency of vital energy, and exopathogen is invaded Attacking, heresy enters heat-transformation, and burn saprophytic pus, and the empty key of delay, disperse empty, clear QI being mixed up with turbid QI, and key gap is inaccessible, causes nasal obstruction watery nasal discharge, headache head Swollen, the tired limb of intelligence unconsciousness, body is tired, normal easily diseases caused by exogenous pathogenic factor.Diseases caused by exogenous pathogenic factor posterior nasal sinuses inflammation increases the weight of again, such reciprocal causation, recurrent exerbation.
At present, along with the continuous decline of air quality, pathogenic organisms of respiratory tract infects and immunologic function disorder inflammation is extensive Popular, cause chronic sinusitis sickness rate also cumulative year after year, patient's course of disease typically lasts for even several years several months, has had a strong impact on trouble The quality of life of person.Treatment chronic sinusitis is many with vasoconstrictor or be equipped with the nasal drop such as antibiotic, hormone clinically, though So can play certain therapeutical effect, but after these medicine life-time service, both be unfavorable for the recovery of nasal mucosa physiological function, with Time it is also possible to cause medicamentous rhinitis, therapeutic effect is undesirable.
Summary of the invention
Not enough for prior art, the invention provides a kind of pharmaceutical composition treating chronic sinusitis, medicine of the present invention Compositions treatment chronic sinusitis not only special effect, controls difficulty in relapse after healing, and has no side effect, preparation technology letter Single.
For achieving the above object, the present invention adopts the technical scheme that: according to the pathogeny of acute and chronic nasal sinusitis, expectorant is turbid Pus is pathological product, is again the new cause of disease.Therefore remove the turbid pus of expectorant, stopping the turbid source of expectorant is the key curing primary disease, rises Clear the turbid descending is then the most basic most effective therapeutic rules.Pharmaceutical composition of the present invention is mainly made up of following crude drug: Radix Pseudostellariae, Poria, Semen Coicis, Fructus Forsythiae, Herba Patriniae, Rhizoma Wenyujin Concisum, Ramulus Cinnamomi, Herba Asari, Rhizoma Ligustici, Fructus Gleditsia, Radix Platycodonis, Rhizoma Cynanchi Stauntonii, Semen Sinapis, Radix Paeoniae Rubra.Fang Zhongtai Son ginseng, Poria, Semen Coicis, invigorating the spleen and benefiting QI, promoting diuresis to eliminate damp pathogen；Fructus Forsythiae, Herba Patriniae, heat-clearing and toxic substances removing, detumescence and apocenosis；Rhizoma Wenyujin Concisum, Semen Sinapis, Radix Paeoniae Rubra, promoting blood circulation to remove obstruction in the collateral, eliminating stasis to stop pain；Ramulus Cinnamomi, Herba Asari, Rhizoma Ligustici, supporing yang sending down the abnormal ascending QI, expelling wind and cold, sensible pain relieving；Fructus Gleditsia, Radix Platycodonis, in vain Before, lung qi dispersing eliminates the phlegm, logical closing of having one's ideas straightened out.Full side plays clearing heat and expelling damp, replenishing QI to invigorate the spleen, blood circulation promoting and blood stasis dispelling, understanding thing and resolving problem altogether, change turbid evacuation of pus it Merit, treating both the principal and secondary aspects of a disease, it is possible to the chronic sinusitis that effectively treatment a variety of causes causes.
Preferably, pharmaceutical composition of the present invention is made up of the crude drug of following weight portion: Radix Pseudostellariae 10-16 part, Poria 10-20 part, Semen Coicis 20-30 part, Fructus Forsythiae 5-15 part, Herba Patriniae 15-25 part, Rhizoma Wenyujin Concisum 5-10 part, Ramulus Cinnamomi 10-16 part, Herba Asari 5-10 part, Rhizoma Ligustici 10-20 part, Fructus Gleditsia 10-20 part, Radix Platycodonis 15-25 part, Rhizoma Cynanchi Stauntonii 10-18 part, Semen Sinapis 5-15 part, Radix Paeoniae Rubra 10-18 Part.
Preferably, pharmaceutical composition of the present invention is made up of the crude drug of following weight portion: Radix Pseudostellariae 12-14 part, Poria 14-16 part, Semen Coicis 24-26 part, Fructus Forsythiae 8-12 part, Herba Patriniae 18-22 part, Rhizoma Wenyujin Concisum 7-9 part, Ramulus Cinnamomi 12-14 part, Herba Asari 7- 9 parts, Rhizoma Ligustici 14-16 part, Fructus Gleditsia 14-16 part, Radix Platycodonis 18-22 part, Rhizoma Cynanchi Stauntonii 12-16 part, Semen Sinapis 8-12 part, Radix Paeoniae Rubra 12-16 part.
Preferably, pharmaceutical composition of the present invention is made up of the crude drug of following weight portion: Radix Pseudostellariae 13 parts, Poria 15 Part, Semen Coicis 25 parts, Fructus Forsythiae 10 parts, Herba Patriniae 20 parts, Rhizoma Wenyujin Concisum 8 parts, Ramulus Cinnamomi 13 parts, Herba Asari 8 parts, Rhizoma Ligustici 15 parts, Fructus Gleditsia 15 Part, Radix Platycodonis 20 parts, Rhizoma Cynanchi Stauntonii 14 parts, 10 parts of Semen Sinapis, Radix Paeoniae Rubra 14 parts.
The function of each component of compositions of the present invention cures mainly as follows:
Radix Pseudostellariae, hardship sweet, micro-, flat.Return spleen, lung meridian.Replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung.Tired for insufficiency of the spleen body, inappetence, Weak after being ill, deficiency of both vital energy and Yin, spontaneous perspiration is thirsty, dryness of the lung dry cough.
Poria, sweet, light, flat.GUIXIN, lung, spleen, kidney channel.Promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming.For edema oliguria, phlegm retention is dizzy Throbbing with fear, insufficiency of the spleen lack of appetite, loose stool has loose bowels, irritability, palpitation with fear insomnia.
Semen Coicis, sweet, light, cool.Return spleen, stomach, lung meridian.Spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal, row is dense in heat clearing away.For edema, foot Gas, dysuria, arthralgia chiefly caused by damp pathogen contracture, diarrhea due to hypofunction of the spleen, lung abscess, acute appendicitis；Verruca plana.
Fructus Forsythiae, bitter, it is slightly cold.Return lung, the heart, small intestine meridian.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.For carbuncle, scrofula, acute mastitis, pellet Poison, anemopyretic cold, epidemic febrile disease from the beginning of, warm is joined the army, high hot excessive thirst, and coma sends out speckle, pyretic stranguria urine retention.
Herba Patriniae, pungent, bitter, cool.Enter stomach, large intestine, Liver Channel.Heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, blood circulation promoting competent silt.For acute appendicitis, lung Carbuncle and sore and toxic, the stagnant caused chest and abdomen pain of the excess-heat stasis of blood, puerperal the disease such as the stagnant stomachache of the stasis of blood.
Rhizoma Wenyujin Concisum, pungent, bitter, temperature.Return liver, spleen channel.Removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia.For amenorrhea due to stagnation of blood, menalgia, breast The side of body twinges, rheumatic arthralgia, takes on arm pain, injury from falling down.
Ramulus Cinnamomi, acrid, sweet, warm.GUIXIN, lung, bladder warp.Diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the flat gas that spins.For Anemofrigid cold, coldness and pain in the epigastrium, cold in blood amenorrhea, arthralgia, phlegm retention, edema, cardiopalmus, renal mass.
Herba Asari, pungent, temperature.GUIXIN, lung, kidney channel.Expelling wind and cold, sensible pain relieving, warming the lung to resolve fluid-retention.For anemofrigid cold, have a headache, Toothache, nasal sinusitis of having a stuffy nose, rheumatic arthralgia, phlegm retention is breathed with cough.
Rhizoma Ligustici, pungent, temperature.Return bladder warp.Dispel the wind, cold expelling, dehumidifying, pain relieving.For anemofrigid cold, top, mountain peak pain, rheumatism limb Joint arthralgia pain.
Fructus Gleditsia, pungent；Salty；Temperature；Poisonous.Lung；Large intestine channel.Expelling phlegm for arresting cough；Have one's ideas straightened out to lead to and close；Parasite killing eliminating stagnation.Main productive cough dyspnea with fullness of the chest；In Keep silent in air port；Accumulation and obstruction of sputum；Coma is in silence；Epilepsy；Sore throat；Constipation and anuresis；Carbuncle scabies.
Radix Platycodonis, bitter, pungent, flat.Return lung meridian.Lung qi dispersing, sore-throat relieving, eliminate the phlegm, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, Hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.
Rhizoma Cynanchi Stauntonii, pungent, bitter, tepor.Return lung meridian.Sending down the abnormal ascending QI, expectorant, cough-relieving.Stop up real for lung qi, cough with copious phlegm, fullness in the chest dyspnea with rapid respiration.
Semen Sinapis, pungent, temperature.Return lung meridian.Warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral pain relieving.Breath with cough for cold-phlegm, distending pain in the chest and hypochondrium, expectorant Stagnant meridians, joint numbness, pain, phlegm-damp oozing in the body, carbuncle of yin nature toxic swelling.
Radix Paeoniae Rubra, bitter, it is slightly cold.Return Liver Channel.Clearing away heat and cooling blood, eliminating stasis to stop pain.For maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, Hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, abdominal mass stomachache, injury from falling down, carbuncle skin infection.
The pharmaceutical composition of the treatment chronic sinusitis that the present invention provides, can make various dosage form, preferably as required , pharmaceutical composition of the present invention makes oral formulations, and the most described oral formulations can be oral liquid, granule or capsule Agent, it is preferred that pharmaceutical composition of the present invention makes capsule.Present invention also offers one and prepare above-mentioned prophylactic treatment lower limb The method of the pharmaceutical composition of deep venous thrombosis, the method comprises the following steps: after each component being pulverized respectively, crosses 100 mesh sieves, Mixing mixing, is packed in hard rubber softgel shell and makes capsule.
Detailed description of the invention
Hereinafter the detailed description of the invention of the present invention is described in detail.It should be appreciated that described herein specifically Embodiment is merely to illustrate and explains the present invention, is not limited to the present invention.
Hereinafter will be described the present invention by embodiment.
Embodiment 1 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 10 parts, 10 parts of Poria, the heart of a lotus seed Semen Coicis 20 parts, Fructus Forsythiae 5 parts, Herba Patriniae 15 parts, Rhizoma Wenyujin Concisum 5 parts, Ramulus Cinnamomi 10 parts, Herba Asari 5 parts, Rhizoma Ligustici 10 parts, 10 parts of Fructus Gleditsia, Radix Platycodonis 15 parts, Rhizoma Cynanchi Stauntonii 10 parts, 5 parts of Semen Sinapis, Radix Paeoniae Rubra 10 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Embodiment 2 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 16 parts, 20 parts of Poria, the heart of a lotus seed Semen Coicis 30 parts, Fructus Forsythiae 15 parts, Herba Patriniae 25 parts, Rhizoma Wenyujin Concisum 10 parts, Ramulus Cinnamomi 16 parts, Herba Asari 10 parts, Rhizoma Ligustici 20 parts, 20 parts of Fructus Gleditsia, Radix Platycodonis 25 parts, Rhizoma Cynanchi Stauntonii 18 parts, 15 parts of Semen Sinapis, Radix Paeoniae Rubra 18 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Embodiment 3 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 12 parts, 14 parts of Poria, the heart of a lotus seed Semen Coicis 24 parts, Fructus Forsythiae 8 parts, Herba Patriniae 18 parts, Rhizoma Wenyujin Concisum 7 parts, Ramulus Cinnamomi 12 parts, Herba Asari 7 parts, Rhizoma Ligustici 14 parts, 14 parts of Fructus Gleditsia, Radix Platycodonis 18 parts, Rhizoma Cynanchi Stauntonii 12 parts, 8 parts of Semen Sinapis, Radix Paeoniae Rubra 12 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Embodiment 4 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 14 parts, 16 parts of Poria, the heart of a lotus seed Semen Coicis 26 parts, Fructus Forsythiae 12 parts, Herba Patriniae 22 parts, Rhizoma Wenyujin Concisum 9 parts, Ramulus Cinnamomi 14 parts, Herba Asari 9 parts, Rhizoma Ligustici 16 parts, 16 parts of Fructus Gleditsia, Fructus Citri tangerinae Obstruct 22 parts, Rhizoma Cynanchi Stauntonii 16 parts, 12 parts of Semen Sinapis, Radix Paeoniae Rubra 16 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Embodiment 5 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 13 parts, 15 parts of Poria, the heart of a lotus seed Semen Coicis 25 parts, Fructus Forsythiae 10 parts, Herba Patriniae 20 parts, Rhizoma Wenyujin Concisum 8 parts, Ramulus Cinnamomi 13 parts, Herba Asari 8 parts, Rhizoma Ligustici 15 parts, 15 parts of Fructus Gleditsia, Fructus Citri tangerinae Obstruct 20 parts, Rhizoma Cynanchi Stauntonii 14 parts, 10 parts of Semen Sinapis, Radix Paeoniae Rubra 14 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Comparative example 1 capsule
The present invention treats the pharmaceutical composition of chronic sinusitis and is made up of following medical material: Radix Pseudostellariae 5 parts, 25 parts of Poria, the heart of a lotus seed Semen Coicis 25 parts, Fructus Forsythiae 10 parts, Herba Patriniae 20 parts, Rhizoma Wenyujin Concisum 8 parts, Ramulus Cinnamomi 13 parts, Herba Asari 8 parts, Rhizoma Ligustici 15 parts, 15 parts of Fructus Gleditsia, Fructus Citri tangerinae Obstruct 20 parts, Rhizoma Cynanchi Stauntonii 14 parts, 10 parts of Semen Sinapis, Radix Paeoniae Rubra 6 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
Comparative example 2 capsule
Radix Pseudostellariae 13 parts, 15 parts of Poria, Semen Coicis 25 parts, Herba Patriniae 20 parts, Rhizoma Wenyujin Concisum 8 parts, Ramulus Cinnamomi 13 parts, Rhizoma Ligustici 15 Part, 15 parts of Fructus Gleditsia, Radix Platycodonis 20 parts, Rhizoma Cynanchi Stauntonii 14 parts, 10 parts of Semen Sinapis, Radix Paeoniae Rubra 14 parts.
Preparation technology: weighing after above Chinese medicine component pulverizes respectively according to aforesaid weight portion, cross 100 mesh sieves, mixing is mixed Even, it is packed in hard rubber softgel shell and makes capsule.
When using Chinese medicine preparation of the present invention treatment chronic sinusitis, take prepared capsule, every amount Han crude drug 0.2g, three times a day, each 2-4 grain, take half an hour after meal.
The drug composition oral liquor of the present invention is tested for clinical observation
1, physical data:
Select in January, 2014 in January, 2015 in me Out-patient Department or 200 example patients with chronic sinusitis conducts of ward treatment They are randomly divided into four groups by object of study, often organize 50 examples, wherein treatment group male 22 example, women 18 example, age minimum 18 Year, maximum 66 years old, average (38.26 ± 5.65) year；-10 years half a year of the course of disease, average course of disease (4.54 ± 1.12) year；Compare 1 group Male 21 example, women 19 example, minimum 17 years old of age, maximum 70 years old, average (39.78 ± 6.24) year；The course of disease 8 months-11 years, flat The all course of disease (4.56 ± 1.25) years；Compare 2 groups of male 23 examples, women 17 example, minimum 16 years old of age, maximum 68 years old, averagely (38.46 ± 5.89) year；The course of disease 6 months-11 years, average course of disease (4.48 ± 1.14) year；Compareing 3 groups of male 21 examples, women 19 Example, minimum 17 years old of age, maximum 67 years old, average (38.22 ± 5.35) year；The course of disease 7 months-12 years, average course of disease (4.50 ± 1.10) year.The aspects such as four groups of ages, sex, courses of disease, through statistical procedures, without significant (P ＞ 0.05), have comparable Property.
2, diagnostic criteria
Western medicine diagnose standard: meet Chinese Journal of Otorhinolaryngology Head And Neck Surgery editorial board, Chinese Medical Association's ear,nose & throat head Diagnostic criteria in " diagnosis of chronic nose one sinusitis and treatment guidelines " that neck surgery branch rhinology group is formulated.And per nasal Hole, nasal endoscopy are diagnosed as chronic sinusitis.
Standards of Chinese Medical Syndrome Differentiation: primary symptom is had a stuffy nose, pus tears, dizzy headache, hyposmia；Looking into and see that nasal secretion is many, concha nasalis swells Swollen companion sees that anemophobia is afraid of cold, lustreless complexion, fatigue and weakness, light red tongue or light fat, and tongue is white, and moderate pulse is weak.
3. inclusive criteria:
Meet above-mentioned diagnostic criteria；
Do not accepted the symptomatic treatments such as surgical resection therapy, anti-inflammatory analgesic and immunosuppressant；
Complete clinical data, time medical, vital sign is steady；
The course of disease is more than 3 months persons；Signature Informed Consent Form person.
4, exclusion standard:
Merge severe cardiac pulmonary dysfunction；
Merge Serious respiratory tract disease；
Merge nasal cavity, tumor of sinus of nose sexually transmitted disease (STD) becomes；
Gestation or women breast-feeding their children；
Carry out therapist the most on request.
5, Therapeutic Method:
Treatment group: the capsule of oral embodiment 5 preparation, every amount 0.2g Han crude drug, three times a day, and each 2-4 grain, meal Half an hour after is taken.
Compare 1 group: using fluticasone propionate nasal spray spray nose, every day twice, the most every nostril, side 1 is sprayed；Oral gram Draw mycin sheet 250mg, every day 1 time.
Compare 2 groups: the capsule of oral contrast embodiment 1 preparation, every amount 0.2g Han crude drug, three times a day, each 2-4 Grain, takes after meal half an hour.
Compare 3 groups: the capsule of oral contrast embodiment 2 preparation, every amount 0.2g Han crude drug, three times a day, each 2-4 Grain, takes after meal half an hour.
Four groups of equal continued treatments of patient observe therapeutic effect after 4 weeks, and follow up a case by regular visits to three months determine curative effect.
6, the standard of curative effect evaluation:
Effective: clinical symptoms, sign disappear, nasal sinuses x-ray checks that abnormal sign disappears, and follows up a case by regular visits to 3 months without recurrence.
Effective: nasal obstruction alleviates, pus tears reduce, and headache disappears or alleviates, in, hypertrophic inferior turbinate or middle nasal concha Polypoid changes subtract Gently, middle nasal meatus has a small amount of pus tears, and nasal sinuses x-ray inspection exception sign alleviates.
Invalid: clinical symptoms, sign are without changing, and nasal sinuses x-ray checks that abnormal sign is without changing.
Carry out symptom integral statistics, to nasal obstruction, flow turbid tears, head dusk pain, hyposmia, indolent and listless weak, breast gastral cavity painful abdominal mass is vexed, receive The symptoms such as slow-witted lack of appetite by without, light, in, the most respectively based on 0,1,2,3 points.
7, statistical method
With statistics software SPSS20.0, data being carried out statistical analysis, enumeration data uses x2Inspection；Measurement data By mean ± standard deviationRepresent, carry out t inspection；P ＜ 0.05 represents that between two groups, diversity is notable.
8. therapeutic outcome
8.1 through treatment in 4 weeks, and followed up a case by regular visits to three months, and four groups specifically to treat clinical effectiveness as shown in table 1.
1. 4 groups of table treatment clinical effectiveness
Group n Effective Effectively Invalid Total effective rate
Treatment group 50 45 4 1 98%*◎△
Compare 1 group 50 26 14 10 80%
Compare 2 groups 50 28 14 8 84%
Compare 3 groups 50 26 13 11 78%
Note: compare with compareing 1 group, * P ＜ 0.05, compare with compareing 2 groups,◎P ＜ 0.05, compares with compareing 3 groups,△P ＜ 0.05。
Compared by data above it is found that clinical effective 45 people, total effective rate 98% in treatment group, be superior to comparison 1-3 group, and significant difference, have statistical significance (P ＜ 0.05).Therapeutic component does not compare with the clinical effectiveness compareing 2 and 3 groups Show, change prescription and/or proportioning, it is impossible to reach the therapeutic effect that pharmaceutical composition of the present invention is excellent equally.
Cardinal symptom integral contrast before and after 8.2 4 groups of treatments
After four groups of patient treatments, cardinal symptom integration is remarkably decreased before the most relatively treating, and treatment group improvement degree is the most notable, Respectively with compare each group of 1-3 and compare, significant difference, there is statistical significance (P ＜ 0.05).Concrete data are shown in Table 2.
Cardinal symptom integral contrast before and after table 2. treatment
Note: after treatment, treatment group compares with compareing 1 group, * P ＜ 0.05, compares with compareing 2 groups,◎P ＜ 0.05, and compares 3 Group compares,△P ＜ 0.05.To sum up, the invention provides a kind of pharmaceutical composition and preparation method thereof, this pharmaceutical composition has Clearing heat and expelling damp, replenishing QI to invigorate the spleen, blood circulation promoting and blood stasis dispelling, understanding thing and resolving problem, change the remarkable efficacy of turbid evacuation of pus, it is possible to effectively treatment a variety of causes draws The chronic sinusitis risen, improves patients ' life quality, observes through clinical experiment, medicine composite for curing chronic sinusitis of the present invention Total effective rate reaches 98%, and clinical effectiveness is notable, is worthy of popularization.

Claims (7)

1. the pharmaceutical composition treating chronic sinusitis, it is characterised in that described compositions is by following weight proportioning Medical material is made: Radix Pseudostellariae 10-16 part, Poria 10-20 part, Semen Coicis 20-30 part, Fructus Forsythiae 5-15 part, Herba Patriniae 15-25 part, sheet Rhizoma Curcumae Longae 5-10 part, Ramulus Cinnamomi 10-16 part, Herba Asari 5-10 part, Rhizoma Ligustici 10-20 part, Fructus Gleditsia 10-20 part, Radix Platycodonis 15-25 part, Rhizoma Cynanchi Stauntonii 10- 18 parts, Semen Sinapis 5-15 part, Radix Paeoniae Rubra 10-18 part.
Pharmaceutical composition the most according to claim 1, it is characterised in that described compositions is by the Chinese medicine of following weight proportioning Material is made: Radix Pseudostellariae 12-14 part, Poria 14-16 part, Semen Coicis 24-26 part, Fructus Forsythiae 8-12 part, Herba Patriniae 18-22 part, sheet Rhizoma Zingiberis Recens Yellow 7-9 part, Ramulus Cinnamomi 12-14 part, Herba Asari 7-9 part, Rhizoma Ligustici 14-16 part, Fructus Gleditsia 14-16 part, Radix Platycodonis 18-22 part, Rhizoma Cynanchi Stauntonii 12-16 Part, Semen Sinapis 8-12 part, Radix Paeoniae Rubra 12-16 part.
Pharmaceutical composition the most according to claim 1, it is characterised in that described compositions is by the Chinese medicine of following weight proportioning Material is made: Radix Pseudostellariae 13 parts, 15 parts of Poria, Semen Coicis 25 parts, Fructus Forsythiae 10 parts, Herba Patriniae 20 parts, Rhizoma Wenyujin Concisum 8 parts, Ramulus Cinnamomi 13 parts, Herba Asari 8 parts, Rhizoma Ligustici 15 parts, 15 parts of Fructus Gleditsia, Radix Platycodonis 20 parts, Rhizoma Cynanchi Stauntonii 14 parts, 10 parts of Semen Sinapis, Radix Paeoniae Rubra 14 parts.
4. according to the pharmaceutical composition described in claim 1,2, it is characterised in that the dosage form of this pharmaceutical composition be oral liquid, Granule, capsule.
Pharmaceutical composition the most according to claim 4, it is characterised in that the dosage form of this pharmaceutical composition is preferably capsule Agent.
6. the method for the medicament composition capsule agent that a kind is prepared described in claim 1, it is characterised in that the method includes following Step: after each component being pulverized respectively, crosses 100 mesh sieves, mixing mixing, is packed in hard rubber softgel shell and makes capsule.
7. the pharmaceutical composition as claimed in claim 1 purposes in the medicine of preparation treatment chronic sinusitis.
CN201610487768.5A 2016-06-27 2016-06-27 Medicine composition for treating chronic sinusitis and preparation method thereof Withdrawn CN105999073A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610487768.5A CN105999073A (en) 2016-06-27 2016-06-27 Medicine composition for treating chronic sinusitis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610487768.5A CN105999073A (en) 2016-06-27 2016-06-27 Medicine composition for treating chronic sinusitis and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105999073A true CN105999073A (en) 2016-10-12

Family

ID=57085020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610487768.5A Withdrawn CN105999073A (en) 2016-06-27 2016-06-27 Medicine composition for treating chronic sinusitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105999073A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102671146A (en) * 2012-05-28 2012-09-19 徐伟 Herbal decoction for curing chronic sinusitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102671146A (en) * 2012-05-28 2012-09-19 徐伟 Herbal decoction for curing chronic sinusitis

Similar Documents

Publication Publication Date Title
CN103705863A (en) Traditional Chinese medicine for improving postoperative qi-yin deficiency of thyroid cancer
CN101085269B (en) Internal-applied traditional Chinese medicine composition for treating lung cancer
CN111588828A (en) Chinese medicinal preparation for treating new coronavirus and viral diseases, and its preparation method
CN104147194B (en) Traditional Chinese medicine composition for treating chronic sinusitis
CN103142722B (en) Traditional Chinese medicine composition for treating liver qi depression type irregular menstruation
CN104547736A (en) Medicine for treating goiter
CN101244101B (en) Chinese medicine composition for curing rhinitis
CN104306793A (en) Chinese herba preparation for treating lobar pneumonia
CN105327171A (en) Traditional Chinese medicine electuary for treating mastitis and preparing method thereof
CN105853930A (en) Traditional Chinese medicine composition for treating depression
CN105999073A (en) Medicine composition for treating chronic sinusitis and preparation method thereof
CN105434739A (en) Traditional Chinese medicine composition for treating chalazia and preparation method thereof
CN100473401C (en) Chinese medicine preparation for preventing and treating cerebral thrombus and sequel thereof
CN104857414A (en) Medicine composite for treating chronic simple rhinitis
CN104623152A (en) Traditional Chinese medicine composition for treating thyroid adenoma due to phlegm-damp stagnation and preparation method thereof
CN104258017A (en) Mixed traditional Chinese medicine for treating malignant glaucoma
CN106511721A (en) Traditional Chinese medicine composition used for treating chronic rhinitis and preparing method of traditional Chinese medicine composition
CN104189427A (en) Traditional Chinese medicinal composition for treating wind-cold cough and asthma diseases and application thereof
CN105434533A (en) Traditional Chinese medicine composition for treating liver cancer
CN105288171A (en) Pharmaceutical composition for treating male climacteric syndrome
CN105232661A (en) Traditional Chinese medicine composition for treating mastitis and preparation method thereof
CN105853547A (en) Traditional Chinese medicine composition for treating chronic rhinitis
CN105288344A (en) Traditional Chinese medicinal composition for treating liver and gall calculi, and application thereof
CN105126056A (en) Traditional Chinese medicine composition for treating cervical spondylosis as well as preparation method and use method thereof
CN104042908A (en) Traditional Chinese medicine composition for treating female climacteric syndrome

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20161012